A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum natural product monomers that meet the Lipinski's Rule of Five , a powerful tool for HTS and HCS screening;

xnum compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS);

xnum Chemotherapeutic drugs that can be used for high-throughput and high-content screening.

xnum tumor-targeted drugs that can be used for high-throughput and high-content screening.

xnum drug fragments，a must-have tool for FBDD;

A unique collection of xnum approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening；

A unique collection of xnum anticancer drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum pediatric drugs for high-throughput screening and high-content screening.

A unique collection of xnum GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

A unique collection of xnum diabetes related compounds;

A unique collection of xnum neurotransmitter receptor compounds, can be used for HTS and HCS screening；

A unique collection of xnum natural products for high throughput screening (HTS) and high content screening (HCS);

A collection of xnum natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening.

A unique collection of xnum compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery;

A unique collection of xnum endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening.

A unique collection of xnum stem cell differentiation signaling targeted compounds for high throughput and high content screening;

A unique collection of xnum compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum compounds with antibiotic activity for new antibacterial drug screening;

A collection of xnum small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;

A unique collection of xnum antibacterial bioactive compounds, a powerful tool for antibacterial drug development;

A unique collection of xnum anti-obesity compounds for high throughput and high content screening;

A unique collection of xnum gut microbial metabolites which can be used for HTS and HCS;

Diversity: Selected from 1,600,000 drug-like compounds, xnumcompounds representing 5000 scaffolds selected from a large drug-like chemical source；

A collection of xnum selected human endogenous metabolites for high throughput and high content screening.

A unique collection of 500 natural alkaloids can be used for high throughput and high content screening；

A unique collection of xnum pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen

A unique collection of xnum promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine;

A unique collection of xnum PPI-related compounds for drug screening;

A unique collection of xnum metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum protease and proteasome inhibitors for research in chemical genomics, and drug screening;

A unique collection of xnum cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);

Well-chosen xnum compounds with unique structures targeting nervous system;

A unique collection of xnum cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism；

A unique collection of xnum compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).

It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consists of xnum compounds without compro

A unique collection of xnum natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;

A unique collection of xnum nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs;

A unique collection of xnum monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening；

A unique collection of xnum compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening；

A unique collection of xnum compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study；